Answers are grounded in this paper and cite their sources.
Esteemed Colleagues and Readers!It is with great pleasure and a profound sense of responsibility that we address you as the Editor-in-Chief of Indian Journal of ECMO (IJECMO).As we embark on this journey together, we extend a warm welcome to all members of our scholarly community, embracing both established experts and emerging voices in our field.We take this opportunity to thank our authors, editors and anonymous reviewers, all of whom have volunteered to contribute to the success of the journal.We are indeed indebted to our reviewers who have spared their valuable time and contributed towards this academic endeavor.Indian Journal of ECMO provides an ideal forum for exchange of information in various formats: full length and letter length research papers, survey papers, work-in-progress reports on promising developments, case studies/best practice articles written by expert in this field.Further in an era marked by rapid advancements and evolving paradigms, the role of academic journals becomes increasingly crucial.Our mission at IJECMO is not only to disseminate cutting-edge research but also to foster dialogue, collaboration, and innovation in the complex science of extracorporeal life support.Traditionally reserved for patients with refractory cardiac and respiratory failure, ECMO has expanded its scope to encompass a wide array of clinical scenarios, including airway emergencies where conventional interventions prove inadequate.In such cases, ECMO serves as a bridge to stability, providing vital oxygenation and ventilation support while allowing clinicians the time and space to address underlying issues.One particularly compelling application of ECMO in airway management is its use in endoscopic tracheal procedures.In situations where traditional ventilation methods are either impractical or pose undue risk, ECMO offers a safe and effective alternative, enabling clinicians to perform intricate procedures with confidence and precision.The use of ECMO in poisoned patients is significantly increasing over time.Available retrospective data suggest that patients receiving VA ECMO for refractory shock or cardiac arrest due to poisoning have lower mortality as compared to those who receive VA ECMO for non-poisoning-related indications.The key is the timely initiation of support.By intervening before the multiorgan failure sets in, we can improve their overall prognosis.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: